Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer
Clinical trial NCT02142790 · UNKNOWN
Trial details
- NCT number
- NCT02142790
- Sponsor
- Nanjing Luye Sike Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.